Literature DB >> 16990051

Re-shaping the T cell repertoire: TCR editing and TCR revision for good and for bad.

David H Wagner1.   

Abstract

Protection against the universe of pathogens requires a functional, diverse T cell repertoire. However, the price that is paid for an evolved, effective immune system includes the potential danger of generating autoaggressive T cells. Autoimmune diseases result from inherent breach of tolerance to self-antigens leading to disruption of the regulatory to autoaggressive T cell homeostatic balance. The immune system has evolved mechanisms to control those processes. For T cells, positive and negative selection in the thymus assures that only fully functional, non-self-reactive T cells will populate the periphery. Failure of this central tolerance would result in autoaggressive T cells escaping into the periphery. However, other means of escaping negative selection can occur in the periphery, i.e., TCR revision, or the altering of TCR expression after thymic egress. Here the potential benefits, i.e., expansion and re-shaping of the T cell repertoire as potentiated by TCR editing and revision are considered. Furthermore, the potential to develop autoaggressive TCR and thus enhance autoimmunity is considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990051     DOI: 10.1016/j.clim.2006.08.006

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

Review 1.  Of the multiple mechanisms leading to type 1 diabetes, T cell receptor revision may play a prominent role (is type 1 diabetes more than a single disease?).

Authors:  D H Wagner
Journal:  Clin Exp Immunol       Date:  2016-07-25       Impact factor: 4.330

2.  Cutting Edge: Rag deletion in peripheral T cells blocks TCR revision.

Authors:  J Scott Hale; Kristina T Ames; Tamar E Boursalian; Pamela J Fink
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

3.  Modulation of TCRβ surface expression during TCR revision.

Authors:  Kalynn B Simmons; Maramawit Wubeshet; Kristina T Ames; Catherine J McMahan; J Scott Hale; Pamela J Fink
Journal:  Cell Immunol       Date:  2011-11-15       Impact factor: 4.868

Review 4.  T-cell receptor revision: friend or foe?

Authors:  J Scott Hale; Pamela J Fink
Journal:  Immunology       Date:  2010-02-26       Impact factor: 7.397

5.  An alternative role for Foxp3 as an effector T cell regulator controlled through CD40.

Authors:  Gisela M Vaitaitis; Jessica R Carter; Dan M Waid; Michael H Olmstead; David H Wagner
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

6.  Preferential killing of cancer cells and activated human T cells using ZnO nanoparticles.

Authors:  Cory Hanley; Janet Layne; Alex Punnoose; K M Reddy; Isaac Coombs; Andrew Coombs; Kevin Feris; Denise Wingett
Journal:  Nanotechnology       Date:  2008-07-23       Impact factor: 3.874

7.  Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.

Authors:  Dan M Waid; Gisela M Vaitaitis; Nathan D Pennock; David H Wagner
Journal:  J Leukoc Biol       Date:  2008-05-09       Impact factor: 4.962

8.  Generation of functional, antigen-specific CD8+ human T cells from cord blood stem cells using exogenous Notch and tetramer-TCR signaling.

Authors:  Irina Fernandez; Tracy P Ooi; Krishnendu Roy
Journal:  Stem Cells       Date:  2014-01       Impact factor: 6.277

9.  CD40 interacts directly with RAG1 and RAG2 in autoaggressive T cells and Fas prevents CD40-induced RAG expression.

Authors:  Gisela M Vaitaitis; David H Wagner
Journal:  Cell Mol Immunol       Date:  2013-09-16       Impact factor: 11.530

10.  Receptor revision in CD4 T cells is influenced by follicular helper T cell formation and germinal-center interactions.

Authors:  Lauren E Higdon; Katherine A Deets; Travis J Friesen; Kai-Yin Sze; Pamela J Fink
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.